Active Search for Chronic Thromboembolic Pulmonary Hypertension Does Not Appear Indicated After Acute Pulmonary Embolism
Overview
Authors
Affiliations
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a life threatening but often, by pulmonary endarterectomy, curable disease. The incidence of CTEPH after an acute pulmonary embolism (PE) appears to be much higher than previously thought. Systematic follow-up of patients after PE might increase the number of diagnosed CTEPH patients.
Aim: To study whether, compared to current clinical practice, a systematic search for CTEPH in patients after acute PE would increase the number of patients diagnosed with symptomatic, potentially treatable CTEPH.
Methods: Consecutive patients with a prior diagnosis of acute PE were presented with a questionnaire, designed to establish the presence of either new or worsened dyspnea after the acute PE episode. If so, patients were evaluated for the presence of CTEPH.
Results: PE patients (n=110; 56+/-18 years) were included after a median follow-up of three years. Overall mortality was 34% (37 patients); 1 patient had died due to CTEPH. In total 62 out of 69 questionnaires were returned; 23 patients reported new or worsened dyspnea related to the PE episode, and qualified for additional testing. In 2 patients, CTEPH was already diagnosed prior to this study. None of the remaining patients met the criteria for the diagnosis of CTEPH. The overall incidence of 2.7% (3/110; 95%CI 0.6-7.8%) is in agreement with earlier reported incidences.
Conclusion: Our findings do not point to a role for a systematic search and pro-active approach towards patients with a recent history of pulmonary embolism to increase the number of patients diagnosed with potentially treatable CTEPH.
Chronic thromboembolic pulmonary hypertension: A great mimic.
Arant C, Arant C, Bobbitt D Respir Med Case Rep. 2024; 51:102099.
PMID: 39282053 PMC: 11399792. DOI: 10.1016/j.rmcr.2024.102099.
Dzikowska-Diduch O, Kurnicka K, Lichodziejewska B, Dudzik-Niewiadomska I, Machowski M, Roik M J Clin Med. 2022; 11(24).
PMID: 36555985 PMC: 9784264. DOI: 10.3390/jcm11247369.
Pang W, Zhang Z, Wang Z, Zhen K, Zhang M, Zhang Y Front Med (Lausanne). 2021; 8:721294.
PMID: 34765615 PMC: 8575791. DOI: 10.3389/fmed.2021.721294.
Chronic thromboembolic pulmonary hypertension - still evolving.
Gerges M, Yacoub M Glob Cardiol Sci Pract. 2020; 2020(1):e202011.
PMID: 33150155 PMC: 7590968. DOI: 10.21542/gcsp.2020.11.
Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus.
Lachant D, Bach C, Wilson B, Chengazi V, Goldman B, Lachant N Pulm Circ. 2020; 10(3):2045894020952019.
PMID: 33014336 PMC: 7509735. DOI: 10.1177/2045894020952019.